The U.S. is experiencing interruptions in the supply of BD BACTEC blood culture media bottles because of recent supplier issues. The disruption in supply of this device is expected to impact patient diagnosis, follow up patient management, and antimicrobial stewardship efforts. The FDA recommends laboratories and health care providers consider conservation strategies to prioritize the use of blood culture media bottles, preserving the supply for patients at highest risk.
We recently attended the Centers for Disease Control Laboratory Outreach Communication System (LOCS) call, where they discussed this current BD BACTEC media supply situation.
Recording Now Available from BD BACTEC Blood Culture Bottles Value Analysis Talk
In a customer letter dated June 11, 2024, BD communicated to Premier that they were anticipating a temporary backorder of their BACTEC™ blood culture media bottles. These products are found on BD’s Automated Blood Culture Analyzers, Reagents, Consumables and Service agreement, PP-LA-540.
On July 11, Premier’s subject matter experts held a value analysis talk to address the blood culture bottle shortage. We addressed supply disruptions, reviewed contracted options and product conservation/alternative strategies and discussed the automated blood culture supply chain. The recording is now available.
Visit the BD BACTEC Blood Culture Bottle Supply Disruption page of the Disaster Preparedness and Response community for real-time updates on this issue.
Related resources: Value analysis toolkit for Automated Blood Culture Analyzers, Reagents, Consumables and Service
As additional information regarding the supply situation is available, we will post it here.
Please contact the UISS Team with any questions.
